Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • My profile
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    Dr Chris Macdonald wearing the Immersive Technology Lab headset
    18 March 2025

    Cambridge scientist launches free VR platform that eliminates the fear of public speaking

    Dr Chris Macdonald creates free virtual reality platform that transforms users into skilled and confident public speakers ...

    pulmonary hypertension
    18 March 2025

    Living with Pulmonary Arterial Hypertension: Early Diagnosis, Patient Advocacy, and the Role of Technology

    Co-authored by Maleen Fischer, PHA Europe

    Andy Weymann MD, MBA, Chairman of the Board, SolasCure
    17 March 2025

    SolasCure enrols first patient in a next Phase II clinical trial to advance Aurase Wound Gel

    Phase II clinical trial to determine the efficacy of Aurase Wound Gel at a higher concentration of the active enzyme Tarumase in venous leg ulcersCambridge, UK 17 March 2025: SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic w...

    XP-Design Assay Salmonella Serotyping Solution
    13 March 2025

    Bio-Rad launches XP-Design Assay Salmonella Serotyping Solution for rapid and accurate food safety testing

    HERCULES, Calif. — 10 March  Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostics products, announces the launch of XP-Design Assay Salmonella Serotyping Solution designed for the rapid detection and precise characterization o...

    Arecor logo
    12 March 2025

    Arecor establishes partnership with biopharmaceutical company to develop novel formulation of peptide therapy

    Partner to fund development work with option to acquire rights to proprietary formulation under Arecor’s technology licensing model. ...

    Signing the research agreement at ICT Mumbai  Standing left to right: Prof Manishkumar Yadav, Chemical Engineering Department, ICT and Ankur Pandey Sales Development Manager, H.E.L India Seated left to right: Prof. Anand Patwardhan; Head of Chemical Engineering Department, ICT; Louise Madden, CEO of H.E.L Group; Prof. Virendra Rathod, Former Head of Chemical Engineering Department, ICT
    12 March 2025

    H.E.L Group signs research agreement with the Institute of Chemical Technology (ICT) in Mumbai

    Collaboration with ICT Mumbai will focus on advancing process safety and chemical synthesis in IndiaLondon, UK, 12 March 2025: H.E.L Group (H.E.L), a global developer and manufacturer of innovative laboratory tools for process optimization, safety, and scale-up, today announced a resear...

    Laurence Reid, Ph.D., Non-Executive Director, Shift Bioscience and Jill Reckless, Ph.D., Translation Advisor, Shift Bioscience
    12 March 2025

    Shift Bioscience announces key appointments to advance rejuvenation therapeutics pipeline

    Jill Reckless (CEO, RxCelerate) appointed as Translation Advisor Laurence Reid joins as Non-Executive Director, previously Decibel Therapeutics, Warp Drive Bio, Alnylam, and Millennium PharmaceuticalsCambridge, UK, 12 March 2025: Shift Bioscience, a biotech company using an AI...

    Cambridge Audio Visual Event Production Company - WaveFX
    13 March 2025

    WaveFX revolutionises webcasting & event production with a 5-star approach

    Let’s be honest, most webcasts are either too complicated, too boring, or both. That’s where WaveFX comes in. They believe event production should be stress-free, engaging, and actually fun (yes, even for corporate events!). Whether it’s a hybrid conference, awards show, product launch,...

    A group of people gathered around a podium holding award certificates
    11 March 2025

    Two Milner Institute bio-incubator companies win cofinitive #21toWatch awards

    Two companies based at the Milner Therapeutics Institute bio-incubator have won Cofinitive #21toWatch awards. ...

    Gyles Brandreth resting his face in his hands. Purple background with windmills on it.
    12 March 2025

    Gyles Brandreth urges public to Support CBM UK’s World in Focus Campaign to end avoidable sight loss

    Broadcaster and writer Gyles Brandreth is lending his passionate support to Cambridge based, Global Disability Inclusion charity, CBM UK’s World in Focus campaign, highlighting the urgent need to tackle avoidable sight loss affecting 1.1 billion people worldwide. ...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 103
    • Page 104
    • Current page 105
    • Page 106
    • Page 107
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS